![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 18, 15208-15215, May 4, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Lysophosphatidic acid (LPA) induces diverse
biological responses in many types of cells and tissues by activating
its specific G protein-coupled receptors (GPCRs). Previously, three
cognate LPA GPCRs (LPA1/VZG-1/EDG-2,
LPA2/EDG-4, and LPA3/EDG-7) were identified in
mammals. By contrast, an unrelated GPCR, PSP24, was reported to be a
high affinity LPA receptor in Xenopus laevis oocytes,
raising the possibility that Xenopus uses a very different form of LPA signaling. Toward addressing this issue, we report two
novel Xenopus genes,
xlpA1-1 and
xlpA1-2, encoding LPA1
homologs (~90% amino acid sequence identity with mammalian
LPA1). Both xlpA1-1 and
xlpA1-2 are expressed in oocytes and
the nervous system. Overexpression of either gene in oocytes
potentiated LPA-induced oscillatory chloride ion currents through a
pertussis toxin-insensitive pathway. Injection of antisense
oligonucleotides designed to inhibit
xlpA1-1 and
xlpA1-2 expression in oocytes
eliminated their endogenous response to LPA. Furthermore,
retrovirus-mediated heterologous expression of
xlpA1-1 or
xlpA1-2 in B103 rat neuroblastoma cells
that are unresponsive to LPA conferred LPA-induced cell rounding
and adenylyl cyclase inhibition. These results indicate that
XLPA1-1 and XLPA1-2 are functional
Xenopus LPA receptors and demonstrate the evolutionary
conservation of LPA signaling over a range of vertebrate phylogeny.
The nucleotide sequences reported in this paper have been
submitted to the EMBL/GenBankTM/EBI Data Bank
with accession numbers AJ249843 and AJ249844.
Two Novel Xenopus Homologs of Mammalian
LPA1/EDG-2 Function as Lysophosphatidic Acid Receptors in
Xenopus Oocytes and Mammalian Cells*
,
,
,
**
Department of Pharmacology and
Neurosciences and Biomedical Sciences Programs, School of
Medicine, University of California, San Diego, La Jolla,
California 92093-0636, the § European Molecular Biology
Laboratory, Meyerhofstrasse 1, 69117 Heidelberg, Germany, and the
¶ Division of Molecular Genetics, National Institute of
Neuroscience, Kodaira, Tokyo 187-8502, Japan
*
This work was supported by grants from the National
Institute of Mental Health (to J. C.), the National Institute of
Neuroscience, Japan (to H. K.), and the Uehara Memorial Foundation (to
N. F. and I. I.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
X. Ye Lysophospholipid signaling in the function and pathology of the reproductive system Hum. Reprod. Update, September 1, 2008; 14(5): 519 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lloyd, Q. Tao, S. Lang, and C. Wylie Lysophosphatidic acid signaling controls cortical actin assembly and cytoarchitecture in Xenopus embryos Development, February 15, 2005; 132(4): 805 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Solis-Garrido, A. J. Pintado, E. Andres-Mateos, M. Figueroa, C. Matute, and C. Montiel Cross-talk between Native Plasmalemmal Na+/Ca2+ Exchanger and Inositol 1,4,5-Trisphosphate-sensitive Ca2+ Internal Store in Xenopus Oocytes J. Biol. Chem., December 10, 2004; 279(50): 52414 - 52424. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-S. Im Discovery of new G protein-coupled receptors for lipid mediators J. Lipid Res., March 1, 2004; 45(3): 410 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Virag, D. B. Elrod, K. Liliom, V. M. Sardar, A. L. Parrill, K. Yokoyama, G. Durgam, W. Deng, D. D. Miller, and G. Tigyi Fatty Alcohol Phosphates are Subtype-Selective Agonists and Antagonists of Lysophosphatidic Acid Receptors Mol. Pharmacol., May 1, 2003; 63(5): 1032 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. A. Contos, I. Ishii, N. Fukushima, M. A. Kingsbury, X. Ye, S. Kawamura, J. H. Brown, and J. Chun Characterization of lpa2 (Edg4) and lpa1/lpa2 (Edg2/Edg4) Lysophosphatidic Acid Receptor Knockout Mice: Signaling Deficits without Obvious Phenotypic Abnormality Attributable to lpa2 Mol. Cell. Biol., October 1, 2002; 22(19): 6921 - 6929. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fukushima, I. Ishii, Y. Habara, C. B. Allen, and J. Chun Dual Regulation of Actin Rearrangement through Lysophosphatidic Acid Receptor in Neuroblast Cell Lines: Actin Depolymerization by Ca2+-alpha -Actinin and Polymerization by Rho Mol. Biol. Cell, August 1, 2002; 13(8): 2692 - 2705. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sano, D. Baker, T. Virag, A. Wada, Y. Yatomi, T. Kobayashi, Y. Igarashi, and G. Tigyi Multiple Mechanisms Linked to Platelet Activation Result in Lysophosphatidic Acid and Sphingosine 1-Phosphate Generation in Blood J. Biol. Chem., June 7, 2002; 277(24): 21197 - 21206. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hla, M.-J. Lee, N. Ancellin, J. H. Paik, and M. J. Kluk Lysophospholipids--Receptor Revelations Science, November 30, 2001; 294(5548): 1875 - 1878. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Fischer, N. Nusser, T. Virag, K. Yokoyama, D.-a. Wang, D. L. Baker, D. Bautista, A. L. Parrill, and G. Tigyi Short-Chain Phosphatidates Are Subtype-Selective Antagonists of Lysophosphatidic Acid Receptors Mol. Pharmacol., October 1, 2001; 60(4): 776 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ishii, B. Friedman, X. Ye, S. Kawamura, C. McGiffert, J. J. A. Contos, M. A. Kingsbury, G. Zhang, J. H. Brown, and J. Chun Selective Loss of Sphingosine 1-Phosphate Signaling with No Obvious Phenotypic Abnormality in Mice Lacking Its G Protein-coupled Receptor, LPB3/EDG-3 J. Biol. Chem., August 31, 2001; 276(36): 33697 - 33704. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |